½ÃÀ庸°í¼­
»óǰÄÚµå
1771546

¹Ì±¹ÀÇ ½º¸¶Æ® ¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®, À¯Çüº°, À¯Åë ä³Îº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹®º° ¿¹Ãø, (2025-2030³â)

U.S. Smart Wearable ECG Monitors Market Size, Share & Trends Analysis Report By Type (Chest Straps, Patches), By Distribution Channel (Pharmacies, Online Channel), By End-use, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÃÀå ±Ô¸ð¿Í µ¿Çâ :

¹Ì±¹ÀÇ ½º¸¶Æ® ¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ ½ÃÀå ±Ô¸ð´Â 2024³â 5¾ï 8,691¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 8.39%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÉÇ÷°ü ÁúȯÀ̳ª ºñ¸¸¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁ®, ½ÉÀüµµ(ECG) ¸ð´ÏÅÍ µîÀÇ ¿þ¾î·¯ºí Á¦Ç°ÀÇ Ã¤Åÿ¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

°Ç°­ °ü¸® Á¦°ø¾÷ü°¡ ½ÉÀå »óŸ¦ °¨ÁöÇÏ°í °ü¸®Çϱâ À§ÇÑ º¸´Ù È¿À²ÀûÀ̰í Á¤È®ÇÑ ÆÐÅÏÀ» ã°í Àֱ⠶§¹®¿¡ ½º¸¶Æ® ECG ¸ð´ÏÅ͸µÀÇ ÀÓ»ó½ÃÇèÀÌ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×À» Ȱ¿ëÇÏ¿© ½º¸¶Æ® ECG ½Ã½ºÅÛÀº ºÎÁ¤¸Æ, ½É¹æ ¼¼µ¿ ¹× ±âŸ ½ÉÀå ÀÌ»óÀÇ Á¶±â Áø´ÜÀ» °³¼±Çϰí, ±Ã±ØÀûÀ¸·Î ȯÀÚÀÇ °á°ú¸¦ Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. Heart Rhythm ÀâÁö¿¡ ¹ßÇ¥µÈ ÀÓ»ó½ÃÇè °á°ú¿¡¼­´Â Àΰ£ÀÇ °¨½Ã¿¡ ÀÇÁ¸ÇÏ´Â ¿¬¼Ó ½ÉÀüµµ(ECG) ¸ð´ÏÅͰ¡ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸®(MCT)º¸´Ù ½É°¢ÇÑ ºÎÁ¤¸ÆÀ» Á¤È®ÇÏ°Ô ½Äº°Çϴµ¥ ¶Ù¾î³ª´Ù´Â °ÍÀÌ ¹àÇôÁ³½À´Ï´Ù. Á¤¸Æ °¨Áö¿¡¼­ 200% ÀÌ»ó È¿°ú°¡ ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù. ÀÓ»ó ¿¬±¸ Áõ°¡´Â Á¢±Ù¼ºÀÌ ¶Ù¾î³ª°í ºñħ½ÀÀûÀÌ°í °³º°È­µÈ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀ» ÅëÇØ ½ÉÀåÇ÷°ü °ü¸®¿¡ Çõ¸íÀ» ÀÏÀ¸Å°´Â ÀÌ·¯ÇÑ ±â¼ú¿¡ ´ëÇÑ ½Å·Ú°¡ ³ô¾ÆÁö°í ÀÖÀ½À» °­Á¶ÇÕ´Ï´Ù.

¿ø°Ý ÀÇ·á°¡ Áö¼ÓÀûÀ¸·Î ¼ºÀåÇÏ°í ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÃֽŠECG ÀåÄ¡´Â °Ç°­ °ü¸®¿¡ ÇʼöÀûÀÎ µµ±¸°¡ µÇ¾ú½À´Ï´Ù. ȯÀÚµéÀº ½ÉÀå À̺¥Æ® ¸ð´ÏÅÍ¿Í °°Àº ÈÞ´ë¿ë ECG ¸ð´ÏÅ͸¦ Ȱ¿ëÇÏ¿© µ¥ÀÌÅ͸¦ Áö¼ÓÀûÀ¸·Î ¼öÁýÇϰí ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô Àü¼ÛÇÕ´Ï´Ù. Zheng Yan°ú Sicheng ChenÀº ½ÉÀåÀÇ °Ç°­ »óŸ¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ´Â ºÒ°¡»ç¸® ¸ð¾ç ¿þ¾î·¯ºí ±â±â¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ »ç¶÷µéÀº ÀÇ·á ½Ã¼³À» Á÷Á¢ ¹æ¹®ÇÒ ÇÊ¿ä ¾øÀÌ ¾çÁúÀÇ ÀÇ·á ¼­ºñ½º¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

ƯÈ÷ ½ÉÇ÷°ü ÁúȯÀ» °¡Áø »ç¶÷µé »çÀÌ¿¡¼­ ±â¼úÀûÀ¸·Î ÷´Ü ½º¸¶Æ® ¿þ¾î·¯ºí ECG ¸ð´ÏÅÍÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÓ»ó ȯ°æ ¿Ü¿¡¼­µµ Áö¼ÓÀûÀÌ°í ½Ç½Ã°£À¸·Î ½ÉÀåÀ» ¸ð´ÏÅ͸µÇÏ¿© ºÎÁ¤¸Æ, ½É¹æ¼¼µ¿ ¹× ±âŸ ½ÉÀå ÀÌ»óÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ ½º¸¶Æ® ¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • º¸Á¶ ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¹Ì±¹ ½º¸¶Æ® ¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ : ½ÃÀå ºÐ¼® µµ±¸
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®
  • ±â¼ú »óȲ
  • »ç·Ê ¿¬±¸ ºÐ¼®

Á¦4Àå ¹Ì±¹ÀÇ ½º¸¶Æ® ¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ ½ÃÀå ºÎ¹® ºÐ¼®, À¯Çüº°, 2018-2030

  • Á¤ÀÇ¿Í ¹üÀ§
  • À¯Çü ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ½º¸¶Æ® ¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ ½ÃÀå(À¯Çüº°, 2018³â-2030³â)
  • °¡½¿ ½ºÆ®·¦
  • ÆÐÄ¡

Á¦5Àå ¹Ì±¹ ½º¸¶Æ® ¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ ½ÃÀå ºÎ¹® ºÐ¼®, À¯Åë ä³Îº°, 2018-2030

  • Á¤ÀÇ¿Í ¹üÀ§
  • À¯Åë ä³Î ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ½º¸¶Æ® ¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ ½ÃÀå(À¯Åë ä³Îº°, 2018³â-2030³â)
  • ¾à±¹
  • ¿Â¶óÀΠä³Î
  • ¼ÒºñÀÚ Á÷Á¢ ÆÇ¸Å(DTC)
  • ±âŸ

Á¦6Àå ¹Ì±¹ÀÇ ½º¸¶Æ® ¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ ½ÃÀå ºÎ¹® ºÐ¼®, ÃÖÁ¾ ¿ëµµº°, 2018-2030

  • Á¤ÀÇ¿Í ¹üÀ§
  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ½º¸¶Æ® ¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ ½ÃÀå(ÃÖÁ¾ ¿ëµµº°, 2018³â-2030³â)
  • º´¿ø
  • Ŭ¸®´Ð
  • ȨÄɾî
  • ±âŸ

Á¦7Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷ ºÐ·ù
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • iRhythm Technologies, Inc.
    • SmartCardia
    • Wearlinq
    • HeartBeam, Inc.
    • SmartCardia Inc.
    • GE Healthcare
    • Philips Healthcare
    • Cardiac Insight, Inc.
    • Hill-Rom Holdings, Inc.(HILLROM &WELCH ALLYN)
    • Norav Medical
SHW 25.07.21

Market Size & Trends:

The U.S. smart wearable ECG monitors market size was estimated at USD 586.91 million in 2024 and is expected to grow at a CAGR of 8.39% from 2025 to 2030. Rising concerns about cardiovascular diseases and obesity contribute to the adoption of wearable products such as electrocardiogram (ECG) monitors. A wearable ECG patch incorporates an electrocardiography sensor and an accelerometer to monitor and capture physiological data. Moreover, advancements in ECG technology, including the rise of portable and handheld devices, are significantly driving market growth.

Smart ECG monitoring is experiencing a significant rise in clinical trials as healthcare providers seek more efficient and accurate patterns to detect and manage heart conditions. These trials evaluate advanced wearable ECG devices and smartphone-integrated technologies that continuously monitor cardiac activity in real-time. By leveraging artificial intelligence (AI) and machine learning, smart ECG systems aim to improve early diagnosis of arrhythmias, atrial fibrillation, and other cardiac abnormalities, ultimately enhancing patient outcomes. For instance, clinical trial findings published in Heart Rhythm in June 2021 reveal that continuous electrocardiography (ECG) monitors, which rely on human oversight, are better at accurately identifying significant arrhythmias than mobile cardiac telemetry (MCT). The results show that ECG monitors are over 200% more effective in detecting these arrhythmias. The growing number of clinical studies highlights the increasing belief in these technologies to revolutionize cardiovascular care through more accessible, non-invasive, personalized monitoring solutions.

As telemedicine continues to grow and the demand for remote patient monitoring increases, contemporary ECG machines have become essential tools in healthcare. These devices now feature wireless connectivity , enabling healthcare professionals to monitor their patients' heart activity remotely. Patients utilize portable ECG monitors, such as cardiac event monitors, that continuously collect and transmit data to their healthcare providers. This instantaneous monitoring allows doctors to identify irregularities and initiate timely action when necessary. For instance, in April 2025, researchers Zheng Yan and Sicheng Chen from the University of Missouri introduced a starfish-shaped wearable gadget that monitors heart health in real time. The device easily connects to a smartphone app, offering users health insights and aiding in the detection of potential heart issues. Furthermore, remote ECG monitoring is especially beneficial for those living in rural areas or patients with mobility challenges. With these advancements, such individuals are able to access quality healthcare without needing to physically visit medical facilities. Modern ECG machines have thus significantly transformed patient care, enhancing accessibility and convenience for people worldwide. Thus, such factors are anticipated to boost the market growth.

Increasing adoption of technologically advanced smart wearable ECG monitors, particularly among individuals with cardiovascular conditions. These devices, which include smartwatches and portable ECG monitors, offer continuous, real-time heart monitoring outside of clinical settings, enabling early detection of arrhythmias, atrial fibrillation, and other cardiac abnormalities. This shift toward personalized and preventive healthcare is mainly due to the rising global prevalence of heart diseases, including hypertension and coronary artery disease. Below is the list of trending smart wearable ECG monitors

U.S. Smart Wearable ECG Monitors Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis on industry trends in each of the sub segments from 2018 to 2030. For the purpose of this study, Grand View Research, Inc. has segmented the U.S. smart wearable ECG monitors market report on the basis of type, distribution channel, and end use:

  • Type Outlook (Revenue USD Million, 2018 - 2030)
  • Chest Straps
  • Patches
  • Distribution Channel Outlook (Revenue USD Million, 2018 - 2030)
  • Pharmacies
  • Online Channel
  • Direct-to-Consumer (DTC)
  • Others
  • End Use Outlook (Revenue USD Million, 2018 - 2030)
  • Hospitals
  • Clinics
  • Home Care
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Distribution Channel Outlook
    • 2.2.3. End Use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Smart Wearable ECG Monitors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Smart Wearable ECG Monitors: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Technology Landscape
  • 3.5. Case Study Analysis

Chapter 4. U.S. Smart Wearable ECG Monitors Market Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. U.S. Smart Wearable ECG Monitors Market, by Type, 2018 to 2030
  • 4.5. Chest Straps
    • 4.5.1. Chest Straps market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Patches
    • 4.6.1. Patches market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. Smart Wearable ECG Monitors Market Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Distribution Channel Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. U.S. Smart Wearable ECG Monitors Market, by Distribution Channel, 2018 to 2030
  • 5.5. Pharmacies
    • 5.5.1. Pharmacies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Online Channel
    • 5.6.1. Online Channel market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Direct-to-Consumer (DTC)
    • 5.7.1. Direct-to-Consumer (DTC) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. U.S. Smart Wearable ECG Monitors Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. U.S. Smart Wearable ECG Monitors Market, by End Use, 2018 to 2030
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Clinics
    • 6.6.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Home Care
    • 6.7.1. Home Care market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Profiles
    • 7.3.1. iRhythm Technologies, Inc.
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. SmartCardia
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Wearlinq
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. HeartBeam, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. SmartCardia Inc.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. GE Healthcare
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Philips Healthcare
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Cardiac Insight, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Hill-Rom Holdings, Inc. (HILLROM & WELCH ALLYN)
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Norav Medical
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦